PRCT News and Press, PROCEPT BioRobotics Corporation From 02/14/22

– Symptom reduction and uroflow improvement proved durable and consistent compared to TURP – Larger prostates (≥50 ml) demonstrated a larger safety and efficacy benefit for Aquablation over TURP – 5-year Aquablation retreatment rate wa...

REDWOOD CITY, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present virtuall...

REDWOOD CITY, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it now has five AquaBeam Robotic Systems installed acr...

REDWOOD CITY, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported preliminary unaudited revenue for the fourth quar...

REDWOOD CITY, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- PROCEPT ® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced the appointment of Mary Garrett to its Boar...

PROCEPT BioRobotics (PRCT -1.6%) hit a post-IPO low of $24.92 this morning despite a recent Goldman Sachs note calling the company a top M&A target in biopharma in 2022. PROCEPT is part of Goldman's Healthcare Strategic Assets Basket where analysts see a greater than 15% chance of M&A...

Alnylam Pharmaceuticals (NASDAQ:ALNY), Crispr Therapeutics (NASDAQ:CRSP), Karuna Therapeutics (NASDAQ:KRTX) and six other biopharma names are among potential M&A candidates for 2022, according to Goldman Sachs. The nine new names have been added to Goldman Sach's Healthcare Strategic Asse...

Halvorsen's 13F portfolio value increased from $32.98B to $36.04B this quarter. The number of positions increased from 88 to 96. Viking Global added McDonald’s and increased General Electric, Humana, Brookfield Asset Management, and Parker Hannifin while dropping Aon plc during...

Point Roberts, WA and Delta, BC - November 19, 2021 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Life Sciences and Mining. Today's stocks have been added to our lists of free stock...

Stanley Druckenmiller's Duquesne disclosed its updated portfolio position in its recent 13F filing. It has taken new positions in Coupang (NYSE:CPNG) of 15.5M shares, Oscar Health (NYSE:OSCR) of 0.99M shares, AbCellera Biologics (NASDAQ:ABCL) of 0.66M shares and PROCEPT BioRobotics&...